Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DC vaccine for low-grade glioma
NCT01635283Phase 2Completed
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Jan 2012
- Primary completion
- May 2016
- Countries
- 1
01
Overview
A Phase 2 trial of tumor lysate-pulsed autologous dendritic cell vaccine (Jonsson Comprehensive Cancer Center) in low-grade glioma (LGG), sponsored by UCLA Jonsson Comprehensive Cancer Center. Started Jan 2012; status: completed.
02
Drugs
tumor lysate-pulsed autologous dendritic cell vaccine (Jonsson Comprehensive Cancer Center)
03
Conditions
low-grade glioma (LGG)
Beyond the preview
Go deeper on NCT01635283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01635283.